240 results on '"Serra, Vicenç"'
Search Results
2. Incidence, predictors, and prognostic significance of impaired functional status early after transcatheter aortic valve replacement
3. Impacto de la intervención coronaria percutánea compleja en el estudio previo al TAVI
4. Clinical impact of complex percutaneous coronary intervention in the pre-TAVR workup
5. Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 1-Year Results of the LYTEN Trial
6. Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices
7. Late Bleeding Events in Patients Undergoing Percutaneous Coronary Intervention in the Workup Pre-TAVR
8. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry
9. Balloon- vs Self-Expanding Valve Systems for Failed Small Surgical Aortic Valve Bioprostheses
10. Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent
11. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
12. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
13. Optimal Degree of Balloon-Expandable Transcatheter Valve Oversizing in Patients With Borderline Aortic Annulus Measurements: Insights From a Multicenter Real-World Experience
14. Late arrhythmias in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement using a balloon-expandable valve
15. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement
16. Procedural Characteristics and Late Outcomes of Percutaneous Coronary Intervention in the Workup Pre-TAVR
17. Late Cerebrovascular Events Following Transcatheter Aortic Valve Replacement
18. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry
19. Late Electrocardiographic Changes in Patients With New-Onset Left Bundle Branch Block Following Transcatheter Aortic Valve Implantation
20. Incidence, predictors, and prognostic significance of impaired functional status early after transcatheter aortic valve replacement
21. Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block Following TAVR
22. Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial.
23. Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial.
24. The Learning Curve and Annual Procedure Volume Standards for Optimum Outcomes of Transcatheter Aortic Valve Replacement: Findings From an International Registry
25. Arrhythmic Burden as Determined by Ambulatory Continuous Cardiac Monitoring in Patients With New-Onset Persistent Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement: The MARE Study
26. Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry
27. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement
28. Institutional experience and outcomes of transcatheter aortic valve replacement: Results from an international multicentre registry
29. Prosthetic Mitral Surgical Valve in Transcatheter Aortic Valve Replacement Recipients: A Multicenter Analysis
30. Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement
31. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial
32. Comparison of Transfemoral Versus Transradial Secondary Access in Transcatheter Aortic Valve Replacement
33. Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement
34. Infective Endocarditis Following Transcatheter Aortic Valve Replacement: Comparison of Balloon- Versus Self-Expandable Valves
35. Therapeutic alternatives after aborted sternotomy at the time of surgical aortic valve replacement in the TAVI Era—Five centre experience and systematic review
36. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
37. Impact of Preexisting Left Bundle Branch Block in Transcatheter Aortic Valve Replacement Recipients
38. Late Cardiac Death in Patients Undergoing Transcatheter Aortic Valve Replacement: Incidence and Predictors of Advanced Heart Failure and Sudden Cardiac Death
39. Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis
40. Clinical Impact of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: Insights Into the Degree and Acuteness of Presentation
41. Impact of New-Onset Persistent Left Bundle Branch Block on Late Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve
42. Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement
43. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients
44. Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation
45. Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement
46. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Complex Coronary Artery Disease
47. Multicenter experience with a second-generation fully-retrievable and repositionable transcatheter aortic valve
48. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients
49. Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement
50. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.